PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: European stocks edge higher in cautious trade

Thu, 06th Apr 2023 08:37

(Alliance News) - Stock prices in London opened higher on Thursday, but sentiment was fragile amid fears of an economic slowdown in the US, and heightened geopolitical tensions.

The FTSE 100 index opened up 28.70 points, 0.4%, at 7,691.64. The FTSE 250 was up 38.53 points, 0.2%, at 18,639.95, and the AIM All-Share was up 1.81 points, 0.2%, at 805.50.

The Cboe UK 100 was up 0.5% at 769.72, the Cboe UK 250 was up 0.6% at 16,231.96, and the Cboe Small Companies was down 0.3% at 13,157.49.

In European equities, the CAC 40 in Paris and the DAX 40 in Frankfurt were each up 0.1%.

Financial markets in the London, Paris, Frankfurt and New York will be closed on Friday to mark Good Friday. However, the US jobs report will still be reported at 1330 BST on Friday.

UK and European markets will remain closed on Easter Monday, while New York re-opens.

Annual growth in UK house prices weakened to levels not seen since October 2019, according to data from Halifax. According to the mortgage lender, average house prices edged up 0.8% in March on a monthly basis. Growth slowed from a 1.2% climb in February. Annually, growth in house prices slowed to 1.6% in March, from the 2.1% climb seen in each of the previous three months.

In London, residential property market slowdown fears hit shares in housebuilder Barratt, down 1.8%, and estate agent Savills, shedding 3.6%.

The dollar was slightly stronger in early exchanges.

Sterling was quoted at USD1.2461 early Thursday, lower than USD1.2471 at the London equities close on Wednesday. The euro traded at USD1.0903, down from USD1.0919. Against the yen, the dollar was quoted at JPY131.36, up versus JPY130.94.

In the US on Wednesday, Wall Street ended mixed, with the Dow Jones Industrial Average ending up 0.2%, the S&P 500 down 0.3% and the Nasdaq Composite down 0.3%.

"A number of US releases suggested that the economy is beginning to wilt under the pressure of the Federal Reserve's aggressive hiking policy, with attention now turning to the scale of a recession, rather than whether one will happen," said interactive investor analyst Richard Hunter.

On Wednesday, survey data from the Institute for Supply Management indicated that the slowdown in the US services sector was faster than expected. The ISM services PMI registered 51.2 in March, its third consecutive month of growth, but down from 55.1 points in February. Markets had expected the reading to dip to 54.5 points, according to FXStreet.

Meanwhile, in Asia on Thursday, the Nikkei 225 index in Tokyo closed down 1.1%. The S&P/ASX 200 in Sydney closed down 0.3%. In China, the Shanghai Composite was marginally lower, while the Hang Seng index in Hong Kong was marginally higher.

Sentiment was unsteady as geopolitical tensions between the world's two largest economies escalated. China sent warships through waters around Taiwan on Thursday as it vowed a "resolute response" to the island's president meeting US House Speaker Kevin McCarthy.

"The fractious relationship between the world's two largest economies is never far from investors' minds, and the latest development was enough to unsettle sentiment, despite some stronger economic readings, most notably a further accelerating services sector in China," ii's Hunter commented.

China's services sector continued to rebound in March, according to the latest survey data on Thursday.

The Caixin services purchasing managers' index rose to 57.8 points in March from 55.0 in February, rising further above the 50-point mark that separates expansion from contraction. It shows a sharp acceleration in the pace of growth.

It was the strongest expansion seen since November 2020, and the third consecutive month of growth.

Meanwhile, developments in Middle Eastern relations may also unnerve the US.

Top diplomats from Middle East rivals Iran and Saudi Arabia met in Beijing on Thursday, pledging to work together to bring "security and stability" to their turbulent region following a surprise China-brokered deal.

In a joint statement released after talks between Iranian Foreign Minister Hossein Amir-Abdollahian and Saudi counterpart Prince Faisal bin Farhan, the two sides vowed to continue to work together to improve ties.

"The oil-rich kingdom has restricted oil output twice against the wishes of the United States, and it has forged goodwill with its neighbouring country, Iran—a country with whom the Saudis have long been at odds," said Zaye Capital Markets' Naem Aslam.

"This predicament has led traders to believe that they need to use extreme caution when deciding which asset class to support," he added.

Brent oil was trading at USD84.56 a barrel early Thursday, up from USD84.48 late Wednesday. It was up sharply from USD79.14 at the market close on Friday, before the surprise production cut announcement from Opec+ last weekend.

In the FTSE 100, Shell rose 2.0% in early trading.

The oil major said it expects a rise in Integrated Gas production in the first quarter of 2023, though it predicted an adjusted corporate loss on a tax hit.

Shell predicted an adjusted loss in its corporate segment between USD900 million and USD1.2 billion, widening from USD600 million in the fourth quarter of 2022. The outcome "includes one-off tax charges", the company said.

It expects Integrated Gas adjusted earnings pre-tax depreciation between USD1.2 and USD1.6 billion, compared to USD1.4 billion in the fourth quarter.

Upstream adjusted earnings are expected between USD2.8 billion to US3.1 billion, compared to USD2.9 billion. For Integrated Gas, it forecast production between 930,000-970,000 barrels of oil equivalent, up from 917,000 boe in the fourth quarter. Upstream production volumes are expected to be within a similar range to the previous quarter, between 1.8 million and 1.9 million boe per day, compared to 1.85 million in the fourth quarter.

Astrazeneca rose 0.9%, on news UK's NHS has approved the use of one of its drugs, which could benefit hundreds of patients with breast cancer and prostate cancer.

Men with advanced prostate cancer and women with HER2-negative early breast cancer who are at high risk of the disease returning will be able to access olaparib through the NHS in England. The decision has been overwhelmingly welcomed, with praise from cancer charities and scientists.

Reckitt Benckinser, ConvaTec and Rentokil fell by 1.9%, 1.2% and 1.3% respectively, as the stocks went ex-dividend.

Gold was quoted at USD2,013.40 an ounce, lower than USD2,021.30, but also up sharply from USD1,979.05 last Friday.

In the FTSE 250, Ferrexpo rose 3.5%.

The iron ore pellet maker updated on its production in the first quarter. Total iron ore pellet production doubled to 901,000 tonnes from the 420,000 tonnes in the fourth quarter. The rise was mostly down to the improvement in electricity supply to its operations in Ukraine, the firm said. This enabled Ferrexpo to restart a second pelletiser line in late February.

Among London's small-caps, Robert Walters fell 3.5%.

The recruitment firm reported a "slower start" to 2023. Net fee income in the first quarter rose 4% year-on-year to GBP102.4 million. It grew 16% in Europe and 18% in Other Internation, helping to offset a 9% decline in the UK and a 1% fall in Asia Pacific. However, on a constant currency basis, net fee income was flat.

"Uncertain global macroeconomic conditions continued to impact recruitment activity levels across a number of the group's markets and disciplines," the firm said.

Robert Walters pointed to the "relatively robust" market fundamentals such as vacancy levels and salary inflation, as well as a global shortage of qualified professionals. It expects the rebound in the Chinese economy, easing inflation and the stabilisation of the technology sector to boost the global outlook.

Still to come on Thursday's economic calendar, there's a UK construction PMI print at 0930 BST. The US weekly unemployment insurance claims will be released at 1330 BST

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.